Research Paper Volume 14, Issue 19 pp 7986—8000
High FHL2 mRNA expression and its prognostic value in lung cancer
Figure 8. The ROC curves and nomogram about FHL2 and RFS in lung cancer. (A) ROC curves evaluating the value of FHL2 for predicting RFS in lung cancer patients. (B) Nomogram predicted 1-year RFS versus actual 1-year RFS. (C) Nomogram predicted 3-year RFS versus actual 3-year RFS. (D) Nomogram predicted 5-year RFS versus actual 5-year RFS. (E–G) Decision curve analysis reflects the feasibility of FHL2 in predicting 1-year, 3-year, and 5-year RFS of patients.